Cycloheptyl CP 55,940 is a synthetic cannabinoid related to CP 55,940 but is a ring-expanded homologue with a cycloheptyl ring in place of the cyclohexyl ring. It was first synthesized by Pfizer in the 1980s. It falls outside the definition of a "cyclohexylphenol derivative" since it does not have a cyclohexyl ring. Cycloheptyl CP 55,940 has similar potency to CP 55,940 itself, with an ED50 of 0.06 mg/kg in animal studies.[1]
 | |
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C25H42O3 |
| Molar mass | 390.608 g·mol−1 |
| 3D model (JSmol) | |
| |
See also
editReferences
edit- ^ US 4371720, Johnson MR, Melvin LS, "2-Hydroxy-4-(substituted) phenyl cycloalkanes and derivatives.", issued 1 February 1983, assigned to Pfizer Inc.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |